These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2908731)

  • 1. [Pharmacology-biochemistry and physiopathology of tardive dyskinesia: review of the latest findings and controversies].
    Gómez-Galera A
    Arch Biol Med Exp; 1988 Jun; 21(1):65-9. PubMed ID: 2908731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tardive dyskinesia: pathophysiology and animal models.
    Casey DE
    J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of tardive dyskinesia in Cebus apella and Macaca speciosa monkeys: a review.
    Domino EF
    Psychopharmacology Suppl; 1985; 2():217-23. PubMed ID: 2860660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic-induced tardive dyskinesia.
    Jenner P; Marsden CD
    Acta Psychiatr Belg; 1987; 87(5):566-98. PubMed ID: 2897761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuroleptic-induced tardive dyskinesia: recent pathophysiological data, therapeutic trials (author's transl)].
    Gaillard-Sizaret C; Gaillard P
    Therapie; 1979; 34(5):555-74. PubMed ID: 44767
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathophysiologic basis of tardive dyskinesia.
    Baldessarini RJ; Tarsy D
    Adv Biochem Psychopharmacol; 1980; 24():451-5. PubMed ID: 6105793
    [No Abstract]   [Full Text] [Related]  

  • 7. Tardive dyskinesia in psychogeriatric patients: a five-year follow-up.
    Mehta D; Mehta S; Mathew P
    J Am Geriatr Soc; 1977 Dec; 25(12):545-7. PubMed ID: 21899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurobiochemical changes in tardive dyskinesia.
    Gunne LM; Häggström JE; Johansson P; Levin ED; Terenius L
    Encephale; 1988 Sep; 14 Spec No():167-73. PubMed ID: 2463901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraventricular nucleus-pineal interaction: relevance to tardive dyskinesia.
    Sandyk R; Kay SR
    Int J Neurosci; 1992 Feb; 62(3-4):269-72. PubMed ID: 1363950
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship of the actions of neuroleptic drugs to the pathophysiology of tardive dyskinesia.
    Baldessarini RJ; Tarsy D
    Int Rev Neurobiol; 1979; 21():1-45. PubMed ID: 43842
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of two iatrogenic dyskinesias.
    Karson CN; Jeste DV; LeWitt PA; Wyatt RJ
    Am J Psychiatry; 1983 Nov; 140(11):1504-6. PubMed ID: 6137963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia?
    Andreassen OA; Jørgensen HA
    Prog Neurobiol; 2000 Aug; 61(5):525-41. PubMed ID: 10748322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A monitoring test for the liability of neuroleptic drugs to induce tardive dyskinesia.
    Gunne LM; Bárány S
    Psychopharmacology (Berl); 1979 Jun; 63(3):195-8. PubMed ID: 39307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental tardive dyskinesia.
    Gunne LM; Häggström JE
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):48-50. PubMed ID: 2858481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Test methods for predicting tardive toxicity of therapeutic drugs using laboratory animals.
    Ando K
    J Toxicol Sci; 1996 Feb; 21(1):105-7. PubMed ID: 8852296
    [No Abstract]   [Full Text] [Related]  

  • 16. Managing antipsychotic-induced tardive dyskinesia.
    Gardos G
    Drug Saf; 1999 Feb; 20(2):187-93. PubMed ID: 10082074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic-opioid interaction: relevance to tardive dyskinesia.
    Sandyk R
    Int J Neurosci; 1986 Aug; 30(1-2):33-6. PubMed ID: 2875043
    [No Abstract]   [Full Text] [Related]  

  • 18. Tardive dyskinesia: a biological appraoch.
    Barbaccia ML; Trabucchi M
    Prog Clin Biol Res; 1980; 39():181-93. PubMed ID: 6105670
    [No Abstract]   [Full Text] [Related]  

  • 19. [Tardive dyskinesia: etiology, clinical features and therapy].
    Furer V; Lichtenberg P; Heresco-Levy U
    Harefuah; 2001 Mar; 140(3):248-52. PubMed ID: 11303354
    [No Abstract]   [Full Text] [Related]  

  • 20. Tardive dyskinesia: a role for the endogenous opioid system.
    Sandyk R
    Med Hypotheses; 1986 Jan; 19(1):71-4. PubMed ID: 2871480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.